ICAL: Impact of Cannabinoids Across Lifespan

ICAL:大麻素对整个生命周期的影响

基本信息

  • 批准号:
    10188473
  • 负责人:
  • 金额:
    $ 218.42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-07-01 至 2023-05-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY: OVERVIEW Teenagers use cannabis more than any other recreational drug. Their developing brains may also be especially vulnerable to its effects, as epidemiological and experimental evidence suggests that frequent cannabis use in adolescence may be associated with impairments in cognitive and affective functioning that continue in adult life. Excessive stimulation of the endogenous cannabinoid (ECB) system – the target of cannabis’s main psychoactive component, Δ9-tetrahydrocannabinol (THC) – is a plausible but still poorly understood mechanism for the long-lasting consequences of cannabis use. We propose the creation of a NIDA Center of Excellence, entitled Impact of Cannabinoids Across Lifespan (ICAL), to test the hypothesis that non-physiological activation of the ECB system in adolescence – caused by exposure to THC – initiates an epigenetically driven reprogramming of the processes that govern the molecular structure, neuroanatomical architecture and synaptic functions of this system, ultimately producing persistent abnormalities in cognition and motivated behavior. To test this hypothesis, ICAL will deploy a vertically integrated strategy combining molecular, neuroanatomical, electrophysiological and behavioral approaches. Specific mechanistic questions will be addressed bringing to bear, as needed, current techniques such as chemogenetic (DREADD) control of neural circuit activity. Synergistic integration within ICAL will be fostered by (a) a shared Administrative Core that will ensure the seamless operation of the center; (b) Animal and Analytical Cores, which will provide a consistent and well-characterized source of experimental subjects for all projects; and (c) a Pilot Core, which will allow for the exploration of important new ideas arising inside or outside the center. A structured set of measures (strict adherence to treatment protocols, animal subject randomization, blind-testing) will ensure the rigor and reproducibility of our studies. A broad program of outreach activities will target the scientific community (through undergraduate/graduate student and faculty mentoring, a bimonthly seminar series and an international “state-of-the-field” workshop, sponsored by the peer-reviewed journal Cannabis and Cannabinoid Research), health care professionals and general public (through an annual Cannabis Awareness Day and a website dedicated to the lay-term dissemination of new scientific discoveries in the field). In a context of rapidly changing laws, social attitudes and economic interests, the enduring consequences of adolescent cannabis use on brain development and mental function remain largely unknown. ICAL’s mission is to fill this knowledge gap while enhancing our mechanistic understanding of the functions serves by the ECB system in the brain, educating a new generation of cannabinoid researchers, and disseminating scientific discoveries about cannabis and its effects.
项目摘要:概述 青少年使用大麻比任何其他娱乐性药物都多。他们正在发育的大脑也可能 特别容易受到其影响,因为流行病学和实验证据表明 青春期频繁吸食大麻可能与认知和情感障碍有关 并在成年生活中持续发挥作用。过度刺激内源性大麻素(ECB) 系统 – 大麻主要精神活性成分 Δ9-四氢大麻酚 (THC) 的目标 – 是 大麻使用的长期后果的一个看似合理但仍知之甚少的机制。 我们建议建立 NIDA 卓越中心,题为“大麻素的影响” 寿命(ICAL),检验 ECB 系统非生理激活的假设 青春期——由接触 THC 引起——启动了表观遗传驱动的重编程 控制分子结构、神经解剖结构和突触功能的过程 这个系统,最终导致认知和动机行为的持续异常。测试 根据这一假设,ICAL 将部署一种垂直整合的战略,结合分子、 神经解剖学、电生理学和行为学方法。具体的机械问题将 根据需要解决现有技术,例如化学遗传学(DREADD) 控制神经回路的活动。 ICAL 内部的协同整合将通过 (a) 共享 行政核心将确保中心的无缝运作; (b) 动物和分析 核心,将为所有人提供一致且特征良好的实验对象来源 项目; (c) 一个试点核心,它将允许探索内部产生的重要新想法 或中心之外。一套结构化的措施(严格遵守治疗方案、动物 受试者随机化、盲测)将确保我们研究的严谨性和可重复性。广泛的 外展活动方案将针对科学界(通过本科生/研究生 学生和教师指导、双月研讨会系列和国际“领域现状” 研讨会,由同行评审期刊《大麻和大麻素研究》赞助)、医疗保健 专业人士和公众(通过一年一度的大麻意识日和网站 致力于该领域新科学发现的外行传播)。在这样的背景下 快速变化的法律、社会态度和经济利益,其持久的后果 青少年吸食大麻对大脑发育和心理功能的影响仍然很大程度上未知。 ICAL 的 使命是填补这一知识空白,同时增强我们对功能的机械理解 由大脑中的 ECB 系统提供服务,教育新一代大麻素研究人员,以及 传播有关大麻及其功效的科学发现。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Daniele Piomelli其他文献

Daniele Piomelli的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Daniele Piomelli', 18)}}的其他基金

The lipid hydrolase NAAA as a target for non-addictive analgesic medications
脂质水解酶 NAAA 作为非成瘾性镇痛药物的靶标
  • 批准号:
    10584428
  • 财政年份:
    2023
  • 资助金额:
    $ 218.42万
  • 项目类别:
ICAL: Impact of Cannabinoids Across Lifespan
ICAL:大麻素对整个生命周期的影响
  • 批准号:
    10399921
  • 财政年份:
    2018
  • 资助金额:
    $ 218.42万
  • 项目类别:
ICAL: Impact of Cannabinoids Across Lifespan: Administrative Core
ICAL:大麻素对整个生命周期的影响:管理核心
  • 批准号:
    10188474
  • 财政年份:
    2018
  • 资助金额:
    $ 218.42万
  • 项目类别:
ICAL: Impact of Cannabinoids Across Lifespan
ICAL:大麻素对整个生命周期的影响
  • 批准号:
    10398657
  • 财政年份:
    2018
  • 资助金额:
    $ 218.42万
  • 项目类别:
ICAL: Impact of Cannabinoids Across Lifespan: Molecular Project
ICAL:大麻素对整个生命周期的影响:分子项目
  • 批准号:
    10188478
  • 财政年份:
    2018
  • 资助金额:
    $ 218.42万
  • 项目类别:
Peripheral FAAH as a target for novel analgesics
外周 FAAH 作为新型镇痛药的靶点
  • 批准号:
    9454448
  • 财政年份:
    2017
  • 资助金额:
    $ 218.42万
  • 项目类别:
Peripheral FAAH as a target for novel analgesics
外周 FAAH 作为新型镇痛药的靶点
  • 批准号:
    9040444
  • 财政年份:
    2017
  • 资助金额:
    $ 218.42万
  • 项目类别:
A Protective role for 2-AG in age-dependent cognitive impairment.
2-AG 在年龄依赖性认知障碍中的保护作用。
  • 批准号:
    9180355
  • 财政年份:
    2016
  • 资助金额:
    $ 218.42万
  • 项目类别:
A Protective role for 2-AG in age-dependent cognitive impairment.
2-AG 在年龄依赖性认知障碍中的保护作用。
  • 批准号:
    9330759
  • 财政年份:
    2016
  • 资助金额:
    $ 218.42万
  • 项目类别:
Lipidomics analysis of identified single neurons in the adult rodent brain
成年啮齿动物大脑中已识别的单个神经元的脂质组学分析
  • 批准号:
    9488668
  • 财政年份:
    2016
  • 资助金额:
    $ 218.42万
  • 项目类别:

相似海外基金

Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 218.42万
  • 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
  • 批准号:
    10738120
  • 财政年份:
    2023
  • 资助金额:
    $ 218.42万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10526768
  • 财政年份:
    2022
  • 资助金额:
    $ 218.42万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10701072
  • 财政年份:
    2022
  • 资助金额:
    $ 218.42万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10679092
  • 财政年份:
    2021
  • 资助金额:
    $ 218.42万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10432133
  • 财政年份:
    2021
  • 资助金额:
    $ 218.42万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10327065
  • 财政年份:
    2021
  • 资助金额:
    $ 218.42万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10377366
  • 财政年份:
    2019
  • 资助金额:
    $ 218.42万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10574496
  • 财政年份:
    2019
  • 资助金额:
    $ 218.42万
  • 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
  • 批准号:
    9403567
  • 财政年份:
    2017
  • 资助金额:
    $ 218.42万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了